SCHEMBL4153639

SCHEMBL4153639

CCCCN(C)C[C@H]1CCCCN1C(=O)c1cc2ncnc(N[C@H](C)c3nc4cc(Cl)ccc4[nH]3)c2cc1Cl

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.35
HSD11B1 P28845 1/20 0.34
GRM5 P41594 3/20 0.34
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
HSD17B10 Q99714 1/20 0.34
PYGL P06737 1/20 0.33
ITGAV P06756 1/20 0.32
ITGA5 P08648 1/20 0.32
ITGB6 P18564 1/20 0.32
SOS1 Q07889 1/20 0.32
EGFR P00533 2/20 0.31
OPRK1 P41145 1/20 0.31
CNR1 P21554 1/20 0.31
CCR2 P41597 1/20 0.31
CCR5 P51681 1/20 0.31
PRCP P42785 1/20 0.31
SLC22A12 Q96S37 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4153641 1.00 ALDH1A1 (0.35) ALDH1A1HSD11B1GRM5KDM4ELMNA
SCHEMBL13772342 1.00 ALDH1A1 (0.35) ALDH1A1HSD11B1GRM5KDM4ELMNA
SCHEMBL4147790 0.94 HSD11B1 (0.34) ALDH1A1HSD11B1GRM5KDM4ELMNA
SCHEMBL13772340 0.94 HSD11B1 (0.34) ALDH1A1HSD11B1GRM5KDM4ELMNA
SCHEMBL4147795 0.94 HSD11B1 (0.34) ALDH1A1HSD11B1GRM5KDM4ELMNA
SCHEMBL8325651 0.94 ALDH1A1 (0.37) ALDH1A1HSD11B1GRM5KDM4ELMNA
SCHEMBL4153331 0.94 ALDH1A1 (0.37) ALDH1A1HSD11B1GRM5KDM4ELMNA
SCHEMBL8322556 0.91 HSD11B1 (0.37) ALDH1A1HSD11B1GRM5KDM4ELMNA
SCHEMBL4158300 0.91 HSD11B1 (0.37) ALDH1A1HSD11B1GRM5KDM4ELMNA
SCHEMBL4158297 0.91 HSD11B1 (0.37) ALDH1A1HSD11B1GRM5KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7429597-B2 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO., KG (DE) 2008-09-30 US claimed
US-20040176603-A1 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-09-09 US claimed
US-20090181958-A1 SUBSTITUTED NITROGEN-CONTAINING HETEROBICYCLES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-07-16 US disclosed
US-7429597-B2 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO., KG (DE) 2008-09-30 US disclosed
US-20040176603-A1 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040176603-A1 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions F11, F12, F2 ALDH1A1 2355/4885HSD11B1 509/4885GRM5 2666/4885
US-20090181958-A1 SUBSTITUTED NITROGEN-CONTAINING HETEROBICYCLES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS F12, F11, F2 ALDH1A1 3364/4885HSD11B1 751/4885GRM5 2849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.